prostate cancer

LDR (Low Dose Rate) prostate brachytherapy has recently been an underutilized treatment for prostate cancer. However, advancements in modern techniques have demonstrated that LDR brachytherapy, a procedure that can be performed quite easily in an ambulatory surgery center, offers high cure rates...

* Interestingly, when analyzing our data by individual patients, 16% exhibited an elevated PSA (≥1 ng/mL) throughout the one-year period. These patients had a median (IQR) baseline PSA of 3.5 (1.8–5.5) ng/mL, which was higher compared to the overall cohort. Notably, three of these patients...

https://bmjoncology.bmj.com/content/4/1/e000520 The main findings of the study on prostate cancer risk in men with testosterone deficiency (TD) and a family history of prostate cancer (PCa) receiving testosterone therapy (TTh) are: - **Prostate Cancer Risk:** There was no significant...

Congratulations to Dr. Thomas Ahlering and Dr. David Lee, both included on Newsweek and Statista's AMERICA'S BEST PROSTATE CANCER SPECIALISTS award list. To spotlight the country's top prostate cancer specialists, Newsweek partnered with Statista for the first annual ranking of America's Best...

Table 1 Guidelines for testosterone therapy in men with prostate cancer Current Evidence and International Medical Organisation’s Guidelines As shown, the guidelines pertaining to testosterone therapy use in hypogonadal men with treated or untreated prostate cancer is shown in Table 1...

Prostate cancer screening is an essential aspect of men’s health, and current advancements in testing are making early detection more precise than ever before. While the PSA (Prostate-Specific Antigen) test has long been the standard, it has limitations and may lead to unnecessary biopsies. The...

Andrew Vickers, PhD, Professor of Healthcare Policy and Research at Weill Cornell Medical College and member of the Memorial Sloan Kettering Cancer Center, Department of Epidemiology and Biostatistics in New York, NY, delivers a nine-minute presentation on the need for reforming the Gleason...

https://www.urologytimes.com/view/testosterone-therapy-and-prostate-cancer-risk-benefit-and-individualized-treatment Key Takeaways Testosterone replacement therapy may not increase prostate cancer recurrence risk, but evidence remains inconclusive, necessitating individualized treatment...

"What is the role of androgen deprivation therapy (ADT) in prostate cancer treatment? In this episode of the BackTable Urology Podcast, Dr. Rana McKay, a medical oncologist from UC San Diego, joins host Dr. Aditya Bagrodia to discuss the administration of ADT and other management strategies for...

Prostate cancer affects 1 in 8 Canadian men, and receiving a positive biopsy result can feel overwhelming. In this video, Dr. Jay Nayak, a leading urologic oncologist in Canada, breaks down how to understand your prostate biopsy pathology report, including Gleason scores and risk levels. Learn...

In this 9-minute presentation, Sigrid Carlsson, MD, PhD, MPH, Memorial Sloan-Kettering Cancer Center, New York, New York, reviews groundbreaking advancements in prostate cancer screening and data from the past year. [/URL] Advances in Prostate Cancer Screening: A Year in Review Presented at the...

Some foods may increase the risk of prostate cancer, while others may help reduce the risk: Red and processed meat Eating red meat, like beef, pork, lamb, or goat, and processed meat, like bacon, ham, and sausage, may increase the risk of prostate cancer. This may be due to heterocyclic...

In this episode, Dr. Morgentaler and Dr. Brandon discuss the controversial topic of testosterone therapy for men diagnosed with or treated for prostate cancer. Chapters 00:00: Introduction to Testosterone and Prostate Cancer - Dr. Morgentaler and Dr. Brandon set the stage by addressing...

Several recent scientific advances have revolutionized treatment for prostate cancer, the most common non-skin cancer in American men. Unfortunately, many patients develop treatment resistance through androgen receptor mutations and other forms of molecular trickery. In this Medical Grand...

Listen closely Dr.Mulhall is always on point! Prostate cancer and its impact on men's sexual health (0:30-9:30) Prostate Health discussion with Dr. John Mulhall of Memorial Sloane Kettering Hospital, Melissa Hadley Barrett, specialist in post prostate rehabilitation, Dr. Elliot Justin...

* TTh can be given to select men after RP. Longer term outcome needs to be assessed. Purpose Testosterone therapy (TTh) in men with T deficiency who have undergone radical prostatectomy (RP) for prostate cancer remains controversial. We aimed to assess the impact of TTh on biochemical...

Focal Therapy Options for Prostate Cancer Host: Jay D. Raman, MD, FACS, FRCS(Glasg) Guest: Ruben Olivares, MD Outline: Segment 1: Why Focal Therapy?Segment 2: Patient selection for Focal Therapy Segment 3: Review of Existing Focal Therapy Modalities Segment 4: How to Build a Successful...

Is Daily PDE5i Supplementation With Trimix ICI Injections Beneficial in Post-Prostate Cancer Treatment? An Evaluation of Efficacy and Safety Data Khalaf Alla , K1; Mahdi, M2; Majzoub, A1; Jacob, J3; Slovacek, H3; Wang, R2 1 - Hamad Medical Corporation 2 - University of Texas Health Science...

* This approach involves administering high doses of testosterone, which has shown significant improvement in 30% of patients, enhancing strength, energy, and sexual function * their research uses blood-based DNA markers to predict which patients will respond best, aiming to personalize...

Chapters 0:49 What is the MiPS2 test and how does it work? 2:14 Can urine tests be used as a partial substitute for biopsies? 4:52 How does the 95% accuracy rate of urine tests affect the screening process? 7:17 What percentage of cancer is missed by different screening methods? 9:25 Can a...

Learning Objectives At the conclusion of this activity, the learner will: 1. Align their practice with current AUA Guidelines (and recent amendments) pertaining to Screening, Diagnosis, and Management of Prostate Cancer. 2. Determine appropriate use of biomarker testing as it relates to...

https://grandroundsinurology.com/episwitch-prostate-screening-pse-blood-test/ Garrett D. Pohlman, MD, discusses his experience with the EpiSwitch® Prostate Screening (PSE) Blood Test in his practice. This presentation was supported by Oxford BioDynamics. He begins with a brief overview of...

The Gabe Canales story and how it can help you and your sons and grandsons. Prostate cancer typically is diagnosed in men in their 60s. It’s considered a disease of aging, an old man’s disease. But Gabe Canales, a marketing & communications expert from Houston Texas, was diagnosed at age 35. It...

In this engaging episode, Dr. Geo sits down with Dr. Behfar Ehdaie, a renowned urologic surgeon from Memorial Sloan Kettering Cancer Center, for an insightful discussion on prostate cancer treatment. The focus is on High-Intensity Focused Ultrasound (HIFU) as a focal therapy for prostate cancer...

A recording of the lecture I gave at Monash University in March 2024 on the topic of men's intimate health. Check out my podcast, The Penis Project, for all things men’s intimate health. I chat to industry-leading experts, clinicians, researchers and patients with lived experience...

In summary, the paper by Melao et al. supports the concept that a low serum T prior to RP may be an adverse prognostic factor and low T may interfere with erectile recovery, but much more work needs to be done. Is there a relationship between testosterone and androgen receptor with...

Did you know androgen deprivation therapy (ADT) lowers testosterone levels, which then causes prostate cancer cells to die? On July 10th, PHEN held a Managing Survivorship Webinar where Dr. Alicia Morgans, Medical Director of the Survivorship Program at the Dana-Farber Cancer Institute, outlined...

Dr. Morgentaler back in action! Listen closely, loved this one! Pros/Cons oral TU (51:24-57:12) * one of the things that the orals have transformed is the concept that you have to have a continually high level of testosterone to get the benefits and clearly that's not true and the...

In this episode of the Dr. Geo Podcast, Dr. Geo sits down with Dr. Xiaosong Meng from UT Southwestern Medical Center to discuss TULSA (Transurethral Ultrasound Ablation), an advanced focal treatment for prostate cancer. They explore how TULSA works, its benefits, and how it compares to other...

In this episode, Dr. Geo Espinosa sits down with Dr. Arvin George, a renowned urologic surgeon from Johns Hopkins specializing in prostate cancer, to delve into the world of focal therapy. They discuss what focal therapy is, its side effects, and various energy types used in treating prostate...

A balance among infections, antimicrobial stewardship and prostate cancer detection: TP vs TRUS prostate biopsy Prostate biopsies are the key step to diagnose prostate cancer and one of the most performed procedures in urology. The biopsy can be performed either the trans-perineal (TP) way or...